| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9975175 | The Journal of Heart and Lung Transplantation | 2005 | 5 Pages |
Abstract
Extended prophylaxis with IV and oral ganciclovir practically abolishes cytomegaloviral disease and is related to a decreased incidence of rejection episodes. However, ganciclovir prophylaxis is not related to a decreased incidence or progression of BOS or survival.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
K.G. Perreas, K. McNeil, S. Charman, L.D. Sharples, T. Wreghitt, J. Wallwork,